Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX1RR3
|
||||
| Drug Name |
(S)-1-(1H-indol-4-yloxy)-3-(4-(6-fluorobenzo[b]thiophen-2-yl)piperidin-1-yl)propan-2-ol
|
||||
| Synonyms |
CHEMBL56601
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H25FN2O2S
|
||||
| Canonical SMILES |
O[C@H](COc1cccc2[nH]ccc12)CN3CCC(CC3)c4cc5ccc(F)cc5s4
|
||||
| InChI |
InChI=1S/C24H25FN2O2S/c25-18-5-4-17-12-23(30-24(17)13-18)16-7-10-27(11-8-16)14-19(28)15-29-22-3-1-2-21-20(22)6-9-26-21/h1-6,9,12-13,16,19,26,28H,7-8,10-11,14-15H2/t19-/m0/s1
|
||||
| InChIKey |
YXCWXVXALVIDQG-IBGZPJMESA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.